These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18439156

  • 21. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H, Liu G, Rea PA, Kruh GD.
    Cancer Res; 2000 Sep 01; 60(17):4779-84. PubMed ID: 10987286
    [Abstract] [Full Text] [Related]

  • 22. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM, Deeley RG, Cole SP.
    Toxicol Appl Pharmacol; 2005 May 01; 204(3):216-37. PubMed ID: 15845415
    [Abstract] [Full Text] [Related]

  • 23. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS, Shah SS, Torbenson MS, Wu TT.
    Hum Pathol; 2016 Sep 01; 55():11-6. PubMed ID: 27137985
    [Abstract] [Full Text] [Related]

  • 24. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
    Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J.
    Biochem Pharmacol; 2005 Sep 15; 70(6):949-58. PubMed ID: 16054595
    [Abstract] [Full Text] [Related]

  • 25. Expression and localization of BCRP, MRP1 and MRP2 in intestines, liver and kidney in horse.
    Tydén E, Bjornstrom H, Tjälve H, Larsson P.
    J Vet Pharmacol Ther; 2010 Aug 15; 33(4):332-40. PubMed ID: 20646193
    [Abstract] [Full Text] [Related]

  • 26. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.
    Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, Müller M.
    Hepatology; 1998 Dec 15; 28(6):1637-44. PubMed ID: 9828229
    [Abstract] [Full Text] [Related]

  • 27. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma.
    Akiyama S, Tamura G, Endoh Y, Fukushima N, Ichihara Y, Aizawa K, Kawata S, Motoyama T.
    Int J Cancer; 2003 Sep 10; 106(4):510-515. PubMed ID: 12845645
    [Abstract] [Full Text] [Related]

  • 28. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney.
    Huls M, van den Heuvel JJ, Dijkman HB, Russel FG, Masereeuw R.
    Kidney Int; 2006 Jun 10; 69(12):2186-93. PubMed ID: 16612327
    [Abstract] [Full Text] [Related]

  • 29. Expression of efflux transporters in human ocular tissues.
    Chen P, Chen H, Zang X, Chen M, Jiang H, Han S, Wu X.
    Drug Metab Dispos; 2013 Nov 10; 41(11):1934-48. PubMed ID: 23979916
    [Abstract] [Full Text] [Related]

  • 30. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
    Alexander D, Yamamoto T, Kato S, Kasai S.
    Surg Today; 1999 Nov 10; 29(5):401-6. PubMed ID: 10333409
    [Abstract] [Full Text] [Related]

  • 31. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
    König J, Rost D, Cui Y, Keppler D.
    Hepatology; 1999 Apr 10; 29(4):1156-63. PubMed ID: 10094960
    [Abstract] [Full Text] [Related]

  • 32. ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine.
    Villanueva S, Zhang W, Zecchinati F, Mottino A, Vore M.
    Curr Med Chem; 2019 Apr 10; 26(7):1155-1184. PubMed ID: 29589524
    [Abstract] [Full Text] [Related]

  • 33. Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions.
    Kang HE, Malinen MM, Saran C, Honkakoski P, Brouwer KLR.
    Drug Metab Dispos; 2019 Oct 10; 47(10):1222-1230. PubMed ID: 31371422
    [Abstract] [Full Text] [Related]

  • 34. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M, Kusuhara H, Onuki R, Ogilvie BW, Parkinson A, Sugiyama Y.
    Drug Metab Dispos; 2009 Oct 10; 37(10):2103-11. PubMed ID: 19628752
    [Abstract] [Full Text] [Related]

  • 35. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y, Ohishi Y, Saito T, Hinoshita E, Uchiumi T, Kinukawa N, Iwamoto Y, Kohno K, Kuwano M, Tsuneyoshi M.
    J Pathol; 2003 Feb 10; 199(2):251-8. PubMed ID: 12533839
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
    Dantzig AH, Shepard RL, Pratt SE, Tabas LB, Lander PA, Ma L, Paul DC, Williams DC, Peng SB, Slapak CA, Godinot N, Perry WL.
    Biochem Pharmacol; 2004 Mar 15; 67(6):1111-21. PubMed ID: 15006547
    [Abstract] [Full Text] [Related]

  • 37. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
    Sentani K, Oue N, Sakamoto N, Arihiro K, Aoyagi K, Sasaki H, Yasui W.
    Mod Pathol; 2008 Apr 15; 21(4):464-75. PubMed ID: 18204429
    [Abstract] [Full Text] [Related]

  • 38. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.
    Donner MG, Keppler D.
    Hepatology; 2001 Aug 15; 34(2):351-9. PubMed ID: 11481620
    [Abstract] [Full Text] [Related]

  • 39. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A, Maeda K, Kamiyama E, Sugiyama D, Kondo T, Shiroyanagi Y, Nakazawa H, Okano T, Adachi M, Schuetz JD, Adachi Y, Hu Z, Kusuhara H, Sugiyama Y.
    Drug Metab Dispos; 2007 Dec 15; 35(12):2166-76. PubMed ID: 17823233
    [Abstract] [Full Text] [Related]

  • 40. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS, Feng B, Nguyen HT, Frederick KS, Campbell SD, Hatch HL, Bi YA, Kazolias DC, Davidson RE, Mireles RJ, Duignan DB, Choo EF, Zhao SX.
    Drug Metab Dispos; 2007 Nov 15; 35(11):2111-8. PubMed ID: 17686907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.